These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3274458)

  • 1. Renal allograft survival in highly sensitized patients treated with cyclosporine.
    Doran M; Coppage M; Ruth J; Fish J; Winsett O; Vaidya S
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1988. PubMed ID: 3274458
    [No Abstract]   [Full Text] [Related]  

  • 2. Recipient sensitization against donor cells in pre- and/or posttransplantation sera is inversely correlated with graft survival.
    Sumitran S; Forsberg I; Lindholm A; Lundgren G; Möller E
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1566-7. PubMed ID: 3274384
    [No Abstract]   [Full Text] [Related]  

  • 3. Renal transplantation in presensitized patients treated with cyclosporine.
    Albrechtsen D; Lundgren G; Bratlie A; Brynger H; Fehrmann I; Frödin L; Gäbel H; Lindholm A; Flatmark A
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1862. PubMed ID: 3274442
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-idiotypic activity in cytotoxic sera from highly sensitised patients (HSP) given cyclosporin A and blood transfusion from a specific donor (ST).
    al-Muzairai IA; MacLeod AM; Cochrane S; Jones MC; Propper D; Catto GR
    Transplant Proc; 1989 Feb; 21(1 Pt 1):748-9. PubMed ID: 2650254
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclosporine A, hyperimmunized patients, and renal retransplantation.
    Hendriks GF; de Lange P; Persijn GG; van Rood JJ
    Transplant Proc; 1987 Feb; 19(1 Pt 1):733-4. PubMed ID: 3274857
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of pretransplant antibodies on early renal allograft rejection.
    Alarif L; Rodriguez R; Blackburn S; Light JA
    Transplant Proc; 1987 Feb; 19(1 Pt 1):771-2. PubMed ID: 3274869
    [No Abstract]   [Full Text] [Related]  

  • 7. Positive B cell crossmatches in highly sensitized patients--influence of antibody specificity on renal transplant outcome.
    Lazda VA; Pollak R; Mozes MF; Jonasson O
    Transplant Proc; 1987 Feb; 19(1 Pt 1):782-4. PubMed ID: 3547840
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of HLA matching and panel reactive antibodies in the development of rejection after conversion of cyclosporine to azathioprine.
    Zemel SM; Shen SY; Weir MR; Dagher FJ; Bentley FR
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2029-31. PubMed ID: 3274466
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal allograft survival in CSA-treated patients with positive donor-specific B cell crossmatches.
    Noreen HJ; van der Hagen E; Bach FH; Najarian JS; Fryd DS
    Transplant Proc; 1989 Feb; 21(1 Pt 1):691-2. PubMed ID: 2650224
    [No Abstract]   [Full Text] [Related]  

  • 10. The impact of cyclosporine A on the DRw6 effect in renal transplantation.
    Hendriks GF; de Lange P; Schreuder GM; D'Amaro J; Persijn GG; van Rood JJ
    Transplant Proc; 1987 Feb; 19(1 Pt 1):650-1. PubMed ID: 3274832
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiidiotypic antibody activity in patients receiving donor specific transfusions and cyclosporine A.
    Stewart KN; Power DA; Hills AN; Catto GR
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2262-3. PubMed ID: 3079078
    [No Abstract]   [Full Text] [Related]  

  • 12. The results of renal transplantation with cyclosporine in immunologically high-risk patients.
    Dickerman RM; Vergne-Marini P; Langley J; Trevino G; Velez R; Brinker K; Nesser D; Long D; Hull AR
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1846-8. PubMed ID: 3079047
    [No Abstract]   [Full Text] [Related]  

  • 13. A past positive crossmatch does not affect allograft survival for cyclosporine-immunosuppressed primary and secondary renal transplant recipients.
    Quinn T; Louis P; Mallis M; Senitzer DS; Tellis V; Matas A
    Transplant Proc; 1989 Feb; 21(1 Pt 1):704. PubMed ID: 2650232
    [No Abstract]   [Full Text] [Related]  

  • 14. Specific HLA antibody production following renal transplantation.
    Martin S; Dyer PA; Gokal R; Mallick NP; Johnson RW
    Transplant Proc; 1987 Feb; 19(1 Pt 1):898. PubMed ID: 3274885
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful transplantation in highly sensitized patients.
    Backman U; Fellström B; Frödin L; Sjöberg O; Tufveson G; Wikström B
    Transplant Proc; 1989 Feb; 21(1 Pt 1):762-3. PubMed ID: 2650261
    [No Abstract]   [Full Text] [Related]  

  • 16. Improved graft survival in highly sensitized patients undergoing renal transplantation after the introduction of a clinically validated flow cytometry crossmatch.
    Limaye S; O'Kelly P; Harmon G; O'Neill D; Dorman AM; Walshe J; Donohoe J; Little D; Conlon PJ; Keogan MT
    Transplantation; 2009 Apr; 87(7):1052-6. PubMed ID: 19352127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of HLA matching on kidney allograft survival.
    Suciu-Foca N; Cohen DJ; Benvenisty AI; Benstein JA; Reed EF; Ho E; Hardy MA
    Transplant Proc; 1996 Feb; 28(1):121-2. PubMed ID: 8644140
    [No Abstract]   [Full Text] [Related]  

  • 18. Kidney graft survival in sensitized, cyclosporine A-treated recipients in Scandiatransplant.
    Jacobsen SE; Fjeldborg O; Madsen M; Lamm LU
    Transplant Proc; 1988 Jun; 20(3):365-6. PubMed ID: 3289162
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of HLA matching, donor age, and cyclosporine on unrelated pediatric renal allograft survival.
    Groenwoud AF; Persijn GG; Hendriks GF; D'Amaro J; Cohen B
    Transplant Proc; 1987 Feb; 19(1 Pt 1):699-701. PubMed ID: 3274847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of HLA-DR and combined HLA-B and HLA-DR matching on early graft outcome under cyclosporine therapy.
    Vanrenterghem Y; Roels L; Waer M; Gruwez J; Dendievel J; Michielsen P
    Transplant Proc; 1987 Feb; 19(1 Pt 1):685-6. PubMed ID: 3274841
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.